The phosphorylation of I kappa B by the multiprotein I kappa B kinase compl
ex (IKC) precedes the activation of transcription factor NF-kappa B, a key
regulator of the inflammatory response. Here we identified the mixed-lineag
e group kinase 3 (MLK3) as an activator of NF-kappa B. Expression of the wi
ld-type form of this mitogen-activated protein kinase kinase kinase (MAPKKK
) induced nuclear immigration, DNA binding, and transcriptional activity of
NF-kappa B. MLM3 directly phosphorylated and thus activated I kappa B kina
se alpha (IKK alpha) and IKK beta, revealing its function as an I kappa B k
inase kinase (IKKK). MLK3 cooperated with the other two IKKKs, MEKK1 and NF
-kappa B-inducing kinase, in the induction of IKK activity. MLK3 bound to c
omponents of the IKC in vivo. This protein-protein interaction was dependen
t on the central leucine zipper region of MLK3. A kinase-deficient version
of MLK3 strongly impaired NF-kappa B-dependent transcription induced by T-c
ell costimulation but not in response to tumor necrosis factor alpha or int
erleukin-l. Accordingly, endogenous MLK3 was phosphorylated and activated b
y T-cell costimulation but not by treatment of cells with tumor necrosis fa
ctor alpha or interleukin-1. A dominant negative version of MLM3 inhibited
NF-kappa B- and CD28RE/AP-dependent transcription elicited by the Rho famil
y GTPases Rac and Cdc42, thereby providing a novel link between these GTPas
es and the IKC.